Xiangdan injection

1. Anti-myocardial ischemia: Intravenous injection of 0.8, 1.6, and 3.2 g/kg of this product can reduce the scope of myocardial infarction in dogs with acute myocardial ischemia caused by ligation of the left anterior descending coronary artery, slow down the acceleration of heart rate caused by ischemia, reduce the release of CK, LDH, and MDA in serum, and enhance SOD activity. 2. Effect on hemodynamics: Intravenous injection of 0.26, 0.78, and 2.34 g/kg of this product can significantly increase the coronary flow and cardiac output of anesthetized dogs, reduce femoral artery systolic pressure (SAP), diastolic pressure (DAP), and mean arterial pressure (MAP). 3. Improve blood rheology: Intravenous injection of 4 g/kg of this product can significantly reduce the whole blood viscosity, hematocrit, and platelet aggregation of rats with blood stasis syndrome caused by intravenous injection of glucose saline, and increase the maximum deformation coefficient of red blood cells. 4. Other effects Oral administration of 0.4 and 0.8 g/kg of this product can reduce experimental liver damage in mice caused by galactosamine, reduce the levels of plasma and liver homogenate peroxide (LPO) and malondialdehyde (MDA), and reduce the levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

Salvia miltiorrhiza

This product is a brown clear liquid.

Intramuscular injection: 2 ml at a time, 1-2 times a day. Intravenous drip: 10-20 ml at a time, diluted with 250-500 ml of 5-10% glucose injection, or as directed by a doctor.

According to literature reports, the use of this product may occasionally cause rash, skin redness and swelling, itching, nausea, vomiting, chills, fever, dizziness, headache, abdominal pain, diarrhea, palpitations, etc. It can cause severe allergic reactions manifested as anaphylactic shock, difficulty breathing, laryngeal edema, etc.

Those who are allergic to this product are prohibited

Not yet clear

Store in a dark, cool place.

2 ml per tube

Hubei Tiansheng Pharmaceutical Co., Ltd.

• Founded in:

  2009-07-15

• Address:

  No. 1, Tiansheng Road, Yunxian Economic Development Zone

• Tax NO.:

  914203046917593145

• Registered Funds:

  101 million yuan

• Email:

  Log in to view